000 01749 a2200529 4500
005 20250513202036.0
264 0 _c20000301
008 200003s 0 0 eng d
022 _a0006-291X
024 7 _a10.1006/bbrc.1999.2018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKruger, E A
245 0 0 _aEndostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cFeb 2000
300 _a183-91 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAngiogenesis Inhibitors
_xgenetics
650 0 4 _aAnimals
650 0 4 _aAntigens, CD34
_xmetabolism
650 0 4 _aAorta, Thoracic
_xdrug effects
650 0 4 _aCollagen
_xgenetics
650 0 4 _aEndostatins
650 0 4 _aEndothelium, Vascular
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMicroscopy, Electron
650 0 4 _aNeovascularization, Physiologic
_xdrug effects
650 0 4 _aPeptide Fragments
_xgenetics
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRecombinant Proteins
_xgenetics
650 0 4 _aSaphenous Vein
_xdrug effects
650 0 4 _aSpecies Specificity
700 1 _aDuray, P H
700 1 _aTsokos, M G
700 1 _aVenzon, D J
700 1 _aLibutti, S K
700 1 _aDixon, S C
700 1 _aRudek, M A
700 1 _aPluda, J
700 1 _aAllegra, C
700 1 _aFigg, W D
773 0 _tBiochemical and biophysical research communications
_gvol. 268
_gno. 1
_gp. 183-91
856 4 0 _uhttps://doi.org/10.1006/bbrc.1999.2018
_zAvailable from publisher's website
999 _c10607268
_d10607268